Topical immunosuppressant and corticosteroid combination

This page covers all Topical immunosuppressant and corticosteroid combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Calcineurin (pimecrolimus); glucocorticoid receptor (fluticasone).

Targets

Calcineurin (pimecrolimus); glucocorticoid receptor (fluticasone)

Marketed (1)

• Combination of pimecrolimus and fluticasone · Children's Hospital of Philadelphia · Dermatology/Immunology
  This combination suppresses skin inflammation by blocking T-cell activation (pimecrolimus) and reducing inflammatory mediator production (fluticasone).

Patent intelligence

• topical immunosuppressant and corticosteroid combination patent landscape — aggregated cliff calendar, attackable patents, originator estates